Pittsburgh () November 15. 2007 -- Despite major efforts to ameliorate the public on the dangers of smoking over the past 40 years a new national survey conducted by the American Legacy Foundation and GlaxoSmithKline Consumer Healthcare an industry leader in smoking cessation indicates major knowledge gaps exist in what smokers believe to be adjust about the risks associated with smoking compared to the actual realities of tobacco-related disease and death. Experts accept these misperceptions may prevent smokers from trying to quit and successfully utilizing proven smoking cessation treatments.
According to the survey while many smokers are aware that smoking can bring about to serious health problems including lung cancer many underestimate the risk of getting the disease from smoking. For example two in three smokers underestimate the come about of developing lung cancer compared to a non-smoker and four in 10 incorrectly accept that developing lung cancer depends more on genes than anything else. Furthermore the analyse open that up to a third of smokers think that certain activities such as exercise and taking vitamins could "change by reversal" most of the effects of smoking.¹
"What is alarming about these survey findings is that so many smokers are comfort so misinformed,” said Dr. Cheryl Healton president and CEO of the American Legacy Foundation. “Proven cessation treatments desire nicotine replacement therapy continue to be underutilized and we believe these misperceptions are partly to accuse. These findings point to the fact that more needs to be done to educate and inform smokers."
Misperceptions about the effects of nicotine found in cigarettes remain at the forefront. Almost all survey respondents (81 to 86 percent) either were unsure whether or incorrectly believed that nicotine caused cancer emphysema or heart attacks.¹ While smoking has been proven to cause cancer heart disease and lung disease long-term use of NRTs are not known to be associated with any serious harmful effects.² These nicotine-related misperceptions can prevent consideration and allot use of smoking cessation aids such as nicotine replacement therapies (NRT).
The survey findings tell smokers dramatically underestimate the safety and efficacy of NRT products such as the nicotine gum patch and lozenge. More than 76 percent of smokers surveyed wrongly accept that or do not know whether. NRTs are more addictive than cigarettes highlighting the be for further education as cigarettes are vastly more addictive.³,⁵ In fact about half of the smokers surveyed stated they would be more likely to believe NRT if they were shown scientific bear witness that be its safety and efficacy.¹
“The analyse reveals that when smokers try quitting with NRT they do not use enough of it or use it for as long as directed on the product's label," said Bill Slivka. President Smoking Control. GlaxoSmithKline Consumer Healthcare. "Study after study shows that when used correctly these products double a smoker's chances of quitting versus cold turkey.⁷ The reality is that most smokers be some type of give when quitting smoking.”
While investigate shows the majority of smokers try to depart “cold turkey,” on any given depart attempt only 3-5 percent of smokers who quit cold turkey are successful long-term.⁸ Tools for cessation such as NRTs social give and counseling undergo been proven to greatly increase the chances of a successful quit attempt.⁹ But the survey revealed that almost three-quarters (72 percent) of smokers surveyed accept that quitting is ''just a matter of ordain cater.''¹ In reality many smokers need support to communicate the addiction to nicotine and smoking. Smokers making a quit attempt should change resources such as counseling opportunities to help understand what to expect and how to command the tough situations when quitting and also consider safe and effective stop-smoking products.
NRT products such as the gum patch and lozenge are among the first-line treatments recommended for all smokers and when used as directed can manifold a smoker’s chances of quitting versus cold turkey.⁷ In fact new research published by Thorax confirms NRT helps "real-world" smokers quit by doubling the odds of successfully quitting long-term and supports the findings of more than 100 randomized clinical trials.¹º NRT is extensively proven to significantly decrease cravings and other withdrawal symptoms during quitting allowing smokers to cerebrate on behavior dress.¹¹ Data from more than 100 clinical trials involving more than 35,000 smokers undergo established a consistent safety and efficacy compose for NRT products over decades of study and use.¹²
About the SurveyA survey of 900 men and women adult smokers in the U. S was fielded in July 2007 by Richard Day Research through an online panel screening for adults age 18 and over who consume cigarettes every day. The data was weighted to adjust for age ethnicity and gender using estimates from the 2006 National Health converse Survey. The "average" respondent in the survey was 48 years of age and started smoking when they were 16 years old smokes 20 cigarettes per day and has tried to quit three times in the past (only 16 percent of respondents have never tried to depart). The survey was conducted on behalf of The American Legacy Foundation and GlaxoSmithKline Consumer Healthcare.
About The American Legacy Foundation®The American Legacy Foundation® is dedicated to building a world where young populate reject tobacco and anyone can quit. Located in Washington. D. C. the foundation develops programs that address the health effects of tobacco use especially among vulnerable populations disproportionately affected by the knell of tobacco through grants technical assistance and training partnerships youth activism and counter-marketing and grassroots marketing campaigns. The foundation’s programs consider truth® a national youth smoking prevention race that has been cited as contributing to significant declines in youth smoking; EX® an innovative public health schedule designed to speak to smokers in their own language and change the way they come quitting; research initiatives exploring the causes consequences and approaches to reducing tobacco use; and a nationally-renowned schedule of outreach to priority populations. The American Legacy Foundation was created as a prove of the November 1998 Master Settlement Agreement (MSA) reached between attorneys general from 46 states five U. S territories and the tobacco industry. Visit.
Way2Quit comWay2depart com is GlaxoSmithKline Consumer Healthcare’s educational website that enables smokers to create an initial quit-smoking plan by completing various assessment tools online. The assessment includes health risks cravings smoking triggers readiness dependency and more. The site also includes helpful tips quitting resources and virtual coaches. For more information visit.
About GlaxoSmithKline Consumer Healthcare GlaxoSmithKline (GSK) Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. GSK offers the widest be of proven NRT products available products which can significantly improve a smoker’s chance of quitting successfully and have.
Forex Groups - Tips on Trading
Related article:
http://userschoice.blogspot.com/2007/11/smokers-remain-unaware-of-health.html
comments | Add comment | Report as Spam
|